Hakima Hannachi

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

Kristy Iglay, Hakima Hannachi, Patrick Joseph Howie et al. · Current Medical Research and Opinion · 2016 · 514 citations

Medicine, Geriatric Medicine, Internal Medicine +17

Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or <scp>TIA</scp>: Insights From the <scp>REACH</scp> Registry

Jérémie Abtan, Deepak L. Bhatt, Yedid Elbez et al. · Clinical Cardiology · 2016 · 60 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +16

Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the <scp>REACH</scp> Registry

Jérémie Abtan, Deepak L. Bhatt, Yedid Elbez et al. · Clinical Cardiology · 2017 · 38 citations · Full text

Medicine, Cardiology, Surgery +14

Ertugliflozin Compared to Other Anti-hyperglycemic Agents as Monotherapy and Add-on Therapy in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis

Ann McNeill, Glenn Davies, Eliza Kruger et al. · Diabetes Therapy · 2019 · 27 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus

Steven B. Heymsfield, Annaswamy Raji, Silvina Gallo et al. · Obesity · 2020 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11